Hussman Strategic Advisors Inc. bought a new position in NovoCure Limited (NASDAQ:NVCR – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 105,000 shares of the medical equipment provider’s stock, valued at approximately $1,871,000. Hussman Strategic Advisors Inc. owned about 0.09% of [...]
Hussman Strategic Advisors Inc. Purchases New Stake in NovoCure Limited (NASDAQ:NVCR)
